Neoplasms Metastasis Completed Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00444678Cetuximab, Capecitabine and Oxaliplatin in Patients With Epidermal Growth Factor Receptor (EGFr) Expressing Metastatic Colorectal CancerTreatment
NCT00123851Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerTreatment
NCT00125034Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)Treatment
NCT00447330Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaTreatment
NCT00851084Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal CancerTreatment